42 2. PRODUCT CONCERNED AND LIKE PRODUCT › 2.2. Claims regarding product scope › 2.2.2. Other product scope claims, Regulation (EU) 2025/2589

In forcesince 18 Dec 2025

After the imposition of provisional measures, CFNA claimed that the Commission should limit the product scope only to one of the two types of the product under investigation, i.e. primary or processed choline chloride, or alternatively to conduct independent assessments. CFNA submitted that primary choline chloride (not mixed with carriers) and processed choline chloride have different market dynamics, as the primary choline chloride offers the EU market with supply chain diversification and price competitiveness, while the processed choline chloride enter in direct competition with EU producers.